IGKV1D-22 and neoplasm: Based on a previous study reporting the role of S100A8/A9 in sustaining the accumulation of MDSC in all lymphoid tissues, we expected that Paquinimod would result in a systemic reduction of the tumor-induced expansion of myeloid cells (8).